TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer

EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) — Translational Research In Oncology (TRIO) today announced a collaboration